This topic contains 0 replies, has 1 voice, and was last updated by  Forum Moderator 1 month, 2 weeks ago.

  • Author
    Posts
  • #14780
     Forum Moderator 
    Keymaster

    UCB is launching a Phase 1b trial to evaluate the efficacy and safety of their therapeutic candidate UCB0599 for the treatment of Parkinson’s disease. Click here to read more about it.

    Are you interested in following this trial as it progresses?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account